Vahanian & Associates Financial Planning Inc. Aquestive Therapeutics, Inc. Transaction History
Vahanian & Associates Financial Planning Inc.
- $24.5 Million
- Q4 2023
A detailed history of Vahanian & Associates Financial Planning Inc. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Vahanian & Associates Financial Planning Inc. holds 591,608 shares of AQST stock, worth $1.47 Million. This represents 4.88% of its overall portfolio holdings.
Number of Shares
591,608
Previous 722,108
18.07%
Holding current value
$1.47 Million
Previous $1.1 Million
8.24%
% of portfolio
4.88%
Previous 3.77%
Shares
9 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$24.3 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$13.8 Million2.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$8.04 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.51 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$3.83 Million0.06% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $132M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...